drugset / Trial / NCT03476772

Nalbuphine Plus Caudal Bupivacaine in Hypospadius Repair

NCT03476772

Completed 60 enrolled Assiut University
RandomizedSingle-groupDouble-blindTreatment

Summary

Caudal aneasthesia for pediatric surgery was first reported in 1933. Since then, studies have described the indications for pediatric caudal block, the level of analgesia, doses, advantages and disadvantages of this technique. In children, caudal anesthesia is most effectively used as adjunct to general aneasthesia and has an opioid-sparing effect, permitting faster and smoother emergence from aneasthesia. A single shot caudal anesthesia provides relatively brief analgesia for 4 to 8 hours depending on the agent used. Prolongation of anesthesia can be achieved by adding various adjuvants, such as opioids and nonopioids such as clonidine, ketamine, midazolam, and neostigmine,with varying degrees of success.

Timeline

Start
2018-03-01
Primary completion
2020-03-01
Completion
2020-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nalbuphine Small molecule 0.1 mg/kg Other

Indications

No indication recorded.